Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Decreased circulating thrombopoietin concentration and Low platelet count (thrombocytopenia); and sometimes findings: Abnormal bleeding tendency (abnormal bleeding). 4 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 3 | Abnormal bleeding tendency (abnormal bleeding), Abnormal platelet aggregation, Low platelet count (thrombocytopenia) |
THPO function has not been fully characterized.
Thrombocytopenia 9 is associated with mutations in the THPO gene on chromosome 3.
Genetic testing for THPO is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for thrombocytopenia 9 has been reported in the published literature.
Phenotype severity distribution: 2 always present features.
No clinical trials have been registered for thrombocytopenia 9.
12 publications have been identified in PubMed for thrombocytopenia 9. Research spans Epidemiology / Natural History (40%), Review / Meta-Analysis (20%), and Clinical Trial Publication (20%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 4 | 40% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 8:46 AM UTC
Online Mendelian Inheritance in Man
2 |
20% |
Clinical study results | 2 | 20% |
Testing and diagnosis research | 1 | 10% |
Patient case studies | 1 | 10% |
Zhao JK (2026). [PMID: 41128656](https://pubmed.ncbi.nlm.nih.gov/41128656/). *Clin Cancer Res*. [Clinical Trial Publication]
Tang X (2026). [PMID: 41978415](https://pubmed.ncbi.nlm.nih.gov/41978415/). *Beijing Da Xue Xue Bao Yi Xue Ban*. [Case Report / Case Series]
Zhang C (2026). [PMID: 42016273](https://pubmed.ncbi.nlm.nih.gov/42016273/). *PeerJ*. [Epidemiology / Natural History]
Schwinger M (2026). [PMID: 40851054](https://pubmed.ncbi.nlm.nih.gov/40851054/). *Eur J Nucl Med Mol Imaging*. [Diagnostic / Biomarker]
Sandeyl AA (2026). [PMID: 41863448](https://pubmed.ncbi.nlm.nih.gov/41863448/). *HIV Res Clin Pract*. [Epidemiology / Natural History]
Hill BT (2025). [PMID: 40397818](https://pubmed.ncbi.nlm.nih.gov/40397818/). *Leuk Lymphoma*. [Clinical Trial Publication]
Jiang M (2025). [PMID: 40980147](https://pubmed.ncbi.nlm.nih.gov/40980147/). *Oncol Lett*. [Review / Meta-Analysis]
Shi J (2025). [PMID: 40135231](https://pubmed.ncbi.nlm.nih.gov/40135231/). *Front Pharmacol*. [Review / Meta-Analysis]
Veve MP (2025). [PMID: 40035548](https://pubmed.ncbi.nlm.nih.gov/40035548/). *Antimicrob Agents Chemother*. [Epidemiology / Natural History]
Daher N (2024). [PMID: 39705153](https://pubmed.ncbi.nlm.nih.gov/39705153/). *Trends Psychiatry Psychother*. [Epidemiology / Natural History]